It is important to note that other relevant mutations typically associated with lung cancer (such as ALK, ROS1, RET, FGFR1, ERBB2, etc.)have been found with frequencies compatible with previously published data, but without a significant difference between subgroups. This evidence concerns the gene RET and lung cancer.